Lidocaine Baxter

Medicinal product

(Invented) name

Lidocaine Baxter

Active substance (s)

Lidokaino hidrochloridas

Strength

20 mg/ml

Pharmaceutical form

injekcinis tirpalas

Route (s) of administration

leisti į veną, leisti į raumenis, leisti po oda

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

N01BB02, Lidocaine

Marketing authorisation holder

Baxter Holding B.V. , Nyderlandai

Date of authorisation

2013-02-28

Date of renewal

2022-05-30

Documents

3234 Lidocaine Baxter 20_perr2022-05-30.docx

3234 pakuotes lapelis_2022-05-30.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

NL/H/2539/002/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

1 ml tirpalo yra:	1 ml
Lidokaino hidrochloridas	20 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
49829	63700	1063700	ampulė	2 ml N10		Receptinis	LT/1/13/3234/009	Netiekiama	-	-	No	-	-
49830	63701	1063701	ampulė	2 ml N25		Receptinis	LT/1/13/3234/010	Netiekiama	-	-	No	-	-
49831	63702	1063702	ampulė	5 ml N10		Receptinis	LT/1/13/3234/011	Tiekiama	-	-	No	-	-
55469	69517	1069517	ampulė	5 ml N25		Receptinis	LT/1/13/3234/012	Netiekiama	-	-	No	-	-
55472	69520	1069520	flakonas	20 ml N1		Receptinis	LT/1/13/3234/013	Netiekiama	-	-	No	-	-
55473	69521	1069521	flakonas	20 ml N10		Receptinis	LT/1/13/3234/014	Netiekiama	-	-	No	-	-
61904	76275	1076275	ampulė	2 ml N5		Receptinis	LT/1/13/3234/017	Netiekiama	-	-	No	-	-
61905	76276	1076276	ampulė	5 ml N5		Receptinis	LT/1/13/3234/018	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2022-05-30	Perregistruotas
2013-02-28	Registruotas